Mark Andrew Sherman - 30 Jan 2025 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Signature
/s/ Daniel Rodriguez as Attorney-in-Fact for Mark Andrew Sherman
Issuer symbol
DLB
Transactions as of
30 Jan 2025
Net transactions value
-$902,302
Form type
4
Filing time
03 Feb 2025, 20:29:47 UTC
Previous filing
18 Dec 2024
Next filing
03 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DLB Class A Common Stock Options Exercise $2,492,800 +40,000 +64% $62.32 102,397 30 Jan 2025 Direct F1
transaction DLB Class A Common Stock Sale $1,245,000 -15,000 -15% $83.00 87,397 30 Jan 2025 Direct F1
transaction DLB Class A Common Stock Sale $2,150,102 -25,000 -29% $86.00 62,397 30 Jan 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DLB Employee Stock Option (Right to Buy) Options Exercise $0 -40,000 -71% $0.000000 16,000 30 Jan 2025 Class A Common Stock 40,000 $62.32 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares held following the reported transactions include 45,470 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
F2 The shares were sold in multiple transactions at prices ranging from $86.00 to $86.195, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F3 This option was granted for a total of 56,000 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date.